ProfoundBio Announces $112 Million Oversubscribed Series B
February 14, 2024
Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its $112 million oversubscribed Series B financing.
SJ Semiconductor Signs $340 Million Series C+ Financing
April 12, 2023
Cooley advised SJ Semiconductor Corporation (SJSemi), a semiconductor foundry, on its $340 million Series C+ financing, with a post-money valuation of close to US$2 billion.
